SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 3-DIMENSIONAL PHARMACEUTICALS (DDDP) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (14)6/14/2001 12:37:26 PM
From: nigel bates  Respond to of 146
 
A fruitful subject for grant applications at the moment -
Message 15934978



To: scaram(o)uche who wrote (14)6/18/2001 10:41:41 PM
From: Spekulatius  Read Replies (1) | Respond to of 146
 
I wonder if BMS recent acquisition of Dupont's drug business may have a (negative) impact on DDDP. DDDP has an drug discovery alliance with BMS and Dupont, and BMS is very likely to cut some fat out of Duponts drug business to make numbers work. Does anyone share this concern?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News